Miyuki Kawase

InstitutionNational Institute of Infectious Diseases
AddressTokyo
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 3 Covid-19 publications, with a maximum of 1 publications in March 2020 and July 2020 and December 2020
    All Publications
    Bar chart showing 19 publications over 11 distinct years, with a maximum of 3 publications in 2012 and 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, Shimojima M, Fukushi S. The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells. J Virol. 2020 12 09; 95(1). PMID: 33055254.
      Citations: 46     Fields:    Translation:HumansAnimalsCells
    2. Kato F, Matsuyama S, Kawase M, Hishiki T, Katoh H, Takeda M. Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2. Microbiol Immunol. 2020 Sep; 64(9):635-639. PMID: 32579258.
      Citations: 17     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    3. Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, Nagata N, Sekizuka T, Katoh H, Kato F, Sakata M, Tahara M, Kutsuna S, Ohmagari N, Kuroda M, Suzuki T, Kageyama T, Takeda M. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A. 2020 03 31; 117(13):7001-7003. PMID: 32165541.
      Citations: 393     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    4. Kawase M, Kataoka M, Shirato K, Matsuyama S. Biochemical Analysis of Coronavirus Spike Glycoprotein Conformational Intermediates during Membrane Fusion. J Virol. 2019 10 01; 93(19). PMID: 31315988.
      Citations: 10     Fields:    Translation:AnimalsCells
    5. Shirato K, Melaku SK, Kawachi K, Nao N, Iwata-Yoshikawa N, Kawase M, Kamitani W, Matsuyama S, Tessema TS, Sentsui H. Middle East Respiratory Syndrome Coronavirus in Dromedaries in Ethiopia Is Antigenically Different From the Middle East Isolate EMC. Front Microbiol. 2019; 10:1326. PMID: 31275264.
      Citations: 10     
    6. Matsuyama S, Shirato K, Kawase M, Terada Y, Kawachi K, Fukushi S, Kamitani W. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells. J Virol. 2018 10 01; 92(19). PMID: 30021905.
      Citations: 31     Fields:    Translation:HumansAnimalsCells
    7. Shirato K, Kawase M, Matsuyama S. Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry. Virology. 2018 04; 517:9-15. PMID: 29217279.
      Citations: 67     Fields:    Translation:HumansCells
    8. Shirato K, Kanou K, Kawase M, Matsuyama S. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry. J Virol. 2017 Jan 01; 91(1). PMID: 27733646.
      Citations: 54     Fields:    Translation:HumansCells
    9. Shirato K, Maejima M, Islam MT, Miyazaki A, Kawase M, Matsuyama S, Taguchi F. Porcine aminopeptidase N is not a cellular receptor of porcine epidemic diarrhea virus, but promotes its infectivity via aminopeptidase activity. J Gen Virol. 2016 10; 97(10):2528-2539. PMID: 27449937.
      Citations: 23     Fields:    Translation:AnimalsCells
    10. Shirato K, Azumano A, Nakao T, Hagihara D, Ishida M, Tamai K, Yamazaki K, Kawase M, Okamoto Y, Kawakami S, Okada N, Fukushima K, Nakajima K, Matsuyama S. Middle East respiratory syndrome coronavirus infection not found in camels in Japan. Jpn J Infect Dis. 2015; 68(3):256-8. PMID: 25993975.
      Citations: 7     Fields:    Translation:AnimalsCells
    11. Shirato K, Imada Y, Kawase M, Nakagaki K, Matsuyama S, Taguchi F. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease. J Med Virol. 2014 Dec; 86(12):2146-53. PMID: 24760654.
      Citations: 42     Fields:    Translation:HumansCells
    12. Shirato K, Kawase M, Matsuyama S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J Virol. 2013 Dec; 87(23):12552-61. PMID: 24027332.
      Citations: 197     Fields:    Translation:HumansCells
    13. Shirato K, Kawase M, Watanabe O, Hirokawa C, Matsuyama S, Nishimura H, Taguchi F. Differences in neutralizing antigenicity between laboratory and clinical isolates of HCoV-229E isolated in Japan in 2004-2008 depend on the S1 region sequence of the spike protein. J Gen Virol. 2012 Sep; 93(Pt 9):1908-1917. PMID: 22673931.
      Citations: 17     Fields:    Translation:HumansCells
    14. Kawase M, Shirato K, van der Hoek L, Taguchi F, Matsuyama S. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J Virol. 2012 Jun; 86(12):6537-45. PMID: 22496216.
      Citations: 215     Fields:    Translation:HumansCells
    15. Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol. 2010 Dec; 84(24):12658-64. PMID: 20926566.
      Citations: 329     Fields:    Translation:HumansAnimalsCells
    16. Kawase M, Shirato K, Matsuyama S, Taguchi F. Protease-mediated entry via the endosome of human coronavirus 229E. J Virol. 2009 Jan; 83(2):712-21. PMID: 18971274.
      Citations: 59     Fields:    Translation:HumansCells